---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-014748"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T14:16:00.527645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma raises ~$20M in Dec 31 offering; believes it now meets Nasdaq equity minimum

## Summary
- Closed Dec 31, 2024 unit offering; gross proceeds ~$20M, up to $52.6M more on warrant exercise.
- Company now believes stockholders' equity is at least $2.5M, addressing Nasdaq Rule 5550(b)(1).
- Awaiting Nasdaq confirmation; no assurance that compliance will be formally determined.
- Hearing panel had granted exception until Feb 18, 2025; filing updates status.

## SEC filing metadata
- accession: 0001104659-25-014748
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925014748/0001104659-25-014748-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925014748/tm256499d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-014748
- JSON: https://secwatch.observer/filing/0001104659-25-014748.json
- Plain text: https://secwatch.observer/filing/0001104659-25-014748.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.